April 10, 2020
Coronavirus

Dr. Quay talks to ABC7 about the Coronavirus HOPE Clinical Trial

coronavirus, covid19

Dr. Steven Quay, CEO of Atossa Therapeutics, proposes a combination of two FDA-approved drugs, heparin and N-acetylcysteine (NAC), to prevent COVID-19 patients from needing ventilators by disrupting the virus’s ability to enter the lungs.

Dubbed H-NAC, this drug combination aims to create a barrier against the virus, akin to peanut butter on car keys hindering access. Quay advocates for a clinical trial, hoping to start within 30 days, with the goal of enabling most COVID-19 patients to manage symptoms at home, reducing hospitalizations and associated risks.

The trial, named the COVID-19 Hope Trial, seeks to demonstrate the effectiveness of H-NAC administered through nebulizers, potentially revolutionizing treatment and alleviating strain on healthcare systems if successful.

Watch and read more here on ABC 7 News.

Steven Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions.

He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine. His contributions to medicine have been cited over 9,600 times. He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 87 US patents. Over 80 million people have benefited from the medicines he invented.

His current passion is the prevention of the two million yearly breast cancer cases worldwide.

Dr. Quay featured in CBS7 on New 2024 COVID Vaccine

September 4, 2024

This summer saw a rise in COVID-19 infections across the U.S., driven by a new variant. To address this, updated vaccines from Moderna and Pfizer have been approved by the FDA and will be available this fall. The CDC notes the virus has been evolving, making regular vaccinations important, especially for those with underlying health conditions.

Lanzamiento de la Nueva Vacuna contra el COVID-19: Lo Que Necesitas Saber para el Otoño de 2024

August 31, 2024

Los casos de COVID-19 están aumentando ligeramente en EE. UU., y se introducirá una nueva vacuna este otoño. Telemundo20 en Texas conversa con el Dr. Quay para discutir los datos más recientes sobre esta vacuna y las precauciones que las personas deben considerar para los próximos meses. A pesar de la presencia continua del virus, actualmente es menos infeccioso y se asemeja a un resfriado común en términos de transmisión.

Monkeypox, Covid Vaccines, And What Tablet Use Is Doing To Our Children

August 27, 2024

Join Dr. Quay’s ElevatorMedicine™ and get FREE, QUICK TIPS for better living, health, and wellness that take less time than riding an elevator!